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Introduction
Macroautophagy, or simply autophagy, refers to a nonspecific 
degradation processes by which cells deliver cytoplasmic sub-
strates to lysosomes for their degradation.1-3 Autophagy is an evo-
lutionarily conserved membrane-trafficking process that operates 
at low basal levels under normal conditions and maintains the 
cellular metabolic balance and homeostasis. Besides its role in 
healthy catabolic processes, autophagy is an important compo-
nent of the host response against infectious agents. For instance, 
autophagy mediates both surveillance and effector functions 
involved in the detection and clearance of viruses.4,5 Thus, strate-
gies aimed at modulating autophagy could be used in the preven-
tion and treatment of infectious diseases.
The first description of autophagy-like structures in virus-
infected cells was made by Palade et al. who visualized poliovirus 
particles inside cell vacuoles similar to autophagosomes.6 Despite 
this early observation, the significance of autophagy in virus 
infections remained elusive until recent years.7 Today, it is known 
that autophagy can play either antiviral or proviral roles during 
viral infection, depending on the virus. For example, the herpes 
simplex virus-1 triggers autophagy8 leading to its degradation in 
host cells9,10 whereas polioviruses11 or dengue virus12,13 use auto-
phagy to favor their replication.
The role(s) played by autophagy in rhabdovirus pathogenesis 
is not fully described yet. In the model organism Drosophila, 
autophagy inhibits both in vitro and in vivo the replication of 
the mammalian rhabdovirus VSV (vesicular stomatitis virus).14 
Furthermore, the glycoprotein G of VSV appears to be the patho-
gen-associated molecular pattern (PAMP) that, after interacting 
with Toll-7 (toll receptor 7), activates the autophagic antiviral 
program.14-16 Whether or not the glycoprotein G plays a similar 
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it has not been elucidated whether or not autophagy is induced by rhabdoviral G glycoproteins (G) in vertebrate 
organisms for which rhabdovirus infection is lethal. Our work provides the first evidence that both mammalian (vesicular 
stomatitis virus, VSV) and fish (viral hemorrhagic septicemia virus, VhSV, and spring viremia carp virus, SVcV) rhabdoviral 
Gs induce an autophagic antiviral program in vertebrate cell lines. The transcriptomic profiles obtained from zebrafish 
genetically immunized with either Gsvcv or Gvhsv suggest that autophagy is induced shortly after immunization and 
therefore, it may be an important component of the strong antiviral immune responses elicited by these viral proteins. 
Pepscan mapping of autophagy-inducing linear determinants of Gvhsv and Gvsv showed that peptides located in their 
fusion domains induce autophagy. Altogether these results suggest that strategies aimed at modulating autophagy 
could be used for the prevention and treatment of rhabdoviral infections such as rabies, which causes thousands of 
human deaths every year.
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role in rhabdovirus vertebrate host organisms for which rhabdo-
viral infection is lethal remains unexplored.
Here we show, for the first time, that autophagy inhibits fish 
rhabdovirus replication. In addition, the glycoprotein G (G) of 3 
different viruses, a mammalian rhabdovirus (VSV), and 2 fish 
rhabdoviruses (viral hemorrhagic septicemia virus, VHSV, and 
spring viremia of carp virus, SVCV) were used to study both 
in vitro and in vivo their potential to induce autophagy in the 
model vertebrate species zebrafish (Danio rerio). Our results 
show that VSV, VHSV, and SVCV Gs, in the absence of other 
viral components, are sufficient to induce a cell’s antiviral 
autophagic program in vitro. Transcriptomic analysis from 
genetically immunized zebrafish as well as in vitro gene 
expression assays suggest that autophagy might contribute 
strongly to the immune responses induced by mammalian and 
fish rhabdoviral Gs. Moreover, the linear regions of rhabdoviral 
Gs involved in inducing autophagy were identified in accor-
dance to their ability to induce autophagy and control rhabdo-
virus infection in vitro. Since immunization strategies to prevent 
and/or control rhabdoviral infections might benefit from the 
use of molecules that promote autophagy to degrade virus par-
ticles or improve their recognition, this study opens the door 
for the development of a new class of antiviral drugs/viral 
vaccine adjuvants. At the same time, this study also highlights 
the importance of increasing the knowledge on host and cellu-
lar barriers against virus infection (e.g., autophagy) to find new 
therapeutic targets.
Results
Fish rhabdoviruses induce antiviral autophagy
To test whether or not fish rhabdoviruses induce autophagy, 
ZF4 cells were infected with VHSV or SVCV. The aggregation 
(puncta formation) of endogenous MAP1LC3A/B (microtu-
bule-associated protein 1 light chain 3, α/β, described as LC3 
henceforth), 2 mammalian orthologs of yeast Atg8, which is 
directly implicated in the membrane-elongation step of auto-
phagosomes17) was assayed 24 h later by IF using an anti-LC3 
antibody. Increased LC3 puncta was observed in both VHSV- 
and SVCV-infected ZF4 cells compared with uninfected cells 
(Fig. 1A). A similar fluorescence expression pattern was observed 
after treating ZF4 cells with rapamycin (rapamycin induces auto-
phagy by inhibiting MTOR [mechanistic target of rapamycin]) 
(Fig. S1).
To check whether replication of SVCV or VHSV was inhibited 
by autophagy, as is the case for VSV,14 3-methyladenine (3MA)-
treated cells (3MA inhibits autophagy by blocking the formation 
of autophagosomes) were infected with VHSV or SVCV and the 
amount of viral particles released after 24 h into the cell culture 
media was titrated. Treatment of cells with 3MA prior to infection 
reduced > 2-fold the SVCV or VHSV yield from infected cells 
compared with cell cultures without 3MA treatment (Fig. 1B) 
indicating that autophagy can inhibit fish rhabdovirus replica-
tion. These results confirm previous reports describing the effect 
of autophagy activation upon VSV replication,14 suggesting that 
this might be a trait common to members of the Rhabdoviridae 
family.
On the other hand, no effects of 3MA or rapamycin on the 
cell viability were observed (not shown).
Activation of authophagy by VSV, VHSV, and SVCV Gs
The implication of other rhabdoviral Gs in the activation 
of antiviral autophagy has been demonstrated in assays using 
UV-inactivated VSV infection and Gvsv-containing vesicu-
lar particles in Drosophila,14,15 an invertebrate model species. 
However, antiviral autophagy induction by rhabdoviral Gs in 
vertebrates has not been tested. This might be an important dif-
ference since, in contrast to VSV infections in Drosophila, rhab-
doviral infections in vertebrates are often lethal. To that end, 
plasmid constructs containing the cDNA sequence coding for 
the VSV, VHSV, or SVCV Gs, fused to the sequence encoding 
the teal fluorescent protein (TFP)18 were obtained and used to 
transfect the fish cell line ZF4 (Gsvcv and Gvhsv) and the mam-
malian cell line HaCaT (Gvsv). Cells transfected with pmTFP 
(encoding monomeric TFP) showed fluorescence diffusely 
distributed in the cytoplasm and the nucleus in both ZF4 and 
HaCaT cells (Fig. 2). In contrast, cells transfected with the plas-
mids encoding the G-TFP fusion proteins showed a relocaliza-
tion of the fluorescence in both cell lines. The majority of these 
cells exhibited a nonuniform granulated cytoplasmic and plasma 
membrane distribution of the fluorescence and the fluorescence 
was excluded from the nuclear region (Fig. 2). No effects of the 
G expression upon cell morphology or viability were observed 
(not shown).
On the other hand, to investigate whether or not zebrafish 
cells might be a good model for studies implicating the G of the 
mammalian rhabdovirus VSV, ZF4 cells were also transfected 
with pGvsv-TFP. Results showed fluorescence indicative of a nor-
mal level of expression of the G protein (Fig. 2).
Likewise, functionality of the 3 fusion proteins seemed correct 
in cell culture as indicated by low-pH dependent fusion assays 
(Fig. S2). G-induced autophagy was then evaluated (Fig. 3). An 
increased number of cells showing fluorescent cytoplasmic puncta 
representing LC3-containing autophagosomes was observed in 
both the ZF4 and HaCaT cells transfected with G-TFP fusion 
proteins (Fig. 3A) compared with both untransfected (not 
shown) and pm-TFP-transfected cells (Fig. S3A and S3C). 
Similar results were obtained after transfection of ZF4 cells with 
pGvsv-TFP (Fig. S3B). Increased autophagy was also observed in 
the cells surrounding G-TFP-transfected cells (Fig. 3A).
In mammals, after autophagy induction, the cytosolic form of 
LC3 (LC3-I) is conjugated on its carboxyl terminus with phos-
phatidylethanolamine forming the lipidated phagophore (auto-
phagosome precursor)/autophagosomal membrane-bound form 
of LC3 (LC3-II). A portion of this LC3-II remains on the mature 
autophagosome. Therefore, the amount of LC3-II correlates with 
the number of autophagosomes and it constitutes the recognized 
consensus marker of this structure. Since anti-LC3 antibodies 
recognize both LC3-I and LC3-II, autophagy progression can 
be also monitored by immunoblotting assays14,19 and quantified 
by calculating the LC3-II/LC3-I ratio. The LC3-II/LC3-I ratios 
(Fig. 3B) in rhabdoviral G-transfected cells (4.92, 4.51 and 2.05 
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for SVCV, VHSV, and VSV G-transfected cells, respectively) 
were ~2-fold higher than in TFP-transfected (1.64 and 0.92 for 
ZF4 and HaCaT cells, respectively) or control cells (1.47 and 
0.23 for ZF4 and HaCaT cells, respectively). These results clearly 
indicate that the conversion of LC3-I to LC3-II was promoted in 
both fish and mammalian cells by the viral glycoproteins after 
transfection. In ZF4 cells the LC3-II/LC3-I ratios were similar in 
G-transfected and UV-inactivated virus infected cells (4.32 and 
4.19 for VHSV-UV and SVCV-UV, respectively). As expected, 
cells infected with live virus (11.04 and 11.64 for SVCV- and 
Figure 1. Autophagy after fish rhabdoviral infection and its antiviral effect in zebrafish cells. (A) ZF4 cells were infected with either SVcV or VhSV (moi 
= 1) or uninfected (u.i.) and fixed after 24 h. cells were then incubated with an antibody anti-Lc3 and stained with a fluorophore-conjugated second-
ary antibody (red fluorescence, Lc3), and DAPi (blue, cell nuclei). images are representative of the results obtained in 2 independent experiments (B) 
Titration in ePc cells of virus in ffu/mL recovered from cell culture media of ZF4 cells with or without 3MA (10 mM) pretreatment and then infected with 
either SVcV (black bars) or VhSV (gray bars) (both at moi = 2). Results represent the mean ± SD of 2 independent experiments each performed in dupli-
cate. ** and ***, Statistically significant (P ≤ 0.05 and P ≤ 0.01, respectively).
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VHSV-infected cells, respectively) or treated with rapamy-
cin (11.06) showed the highest LC3-II/LC3-I ratios (Fig. 3B). 
All together, these experiments demonstrate that i) fluorescent 
puncta are autophagosomes and ii) rhabdoviral Gs are inducing 
autophagosome (LC3-II) formation.
Rhabdoviral Gs also induce autophagy in in-vivo trans-
fected cells
An important question is whether the autophagy induced by 
rhabdoviral Gs in vitro extends to in vivo conditions. If this 
is the case, autophagy should be detected at short times post-
immunization with G. To investigate this aspect and in order 
to keep a certain degree of similitude between both in vitro 
(cell transfection) and in vivo experiments, adult zebrafish 
were genetically immunized by intramuscular injection with 
the G-encoding plasmids (in vivo cell transfection). Three ds 
after immunization, muscle samples at the site of injection were 
taken and processed for a gene expression study. Glycoproteins 
of VHSV and SVCV were chosen for the in vivo assays because 
DNA vaccines based on these glycoproteins, when intramus-
cularly injected, conferred fish protection against virus lethal 
challenges.20-23
First, since the in vivo conditions governing the expression 
of the proteins encoded by the plasmids might be different from 
those in vitro,24 their expression in the muscle (i.e., injection site) 
was assessed by RTqPCR. Expression of both Gs was observed 
(Fig. S4). However, the relative amount of transcripts of the Gs 
(expression values normalized against eef1a1l1 [eukaryotic trans-
lation elongation factor 1 α, like 1] expression) varied from fish 
to fish, although the average expression levels of both Gs were 
similar (Fig. S4).
To investigate how the genes implicated in autophagy are reg-
ulated in response to immunization with the G-encoding plas-
mids, analysis of the whole-transcriptome profiles rather than 
measurement of the expression of several potential candidate 
autophagy related-genes were performed. Thus, we conducted 
a transcriptome analysis from: pAE6-Gvhsv-, pAE6-Gsvcv-, 
pAE6-injected and uninjected (control [C]) zebrafish groups.
Both of the transcriptomic profiles of zebrafish intramuscu-
larly injected with G-encoding plasmids (pAE6-Gsvcv or pAE6-
Gvhsv) showed significant modulation of autophagy-associated 
genes. One hundred 50 genes (Table S2) out of 420 identified 
in mammals as participants of autophagy and autophagy-related 
processes (including genes of the lysosomal pathway),25 and 
present in the microarray used for these experiments, were com-
monly modulated by both pAE6-Gsvcv and pAE6-Gvhsv. The 
results confirm that autophagy-related genes are involved in the 
orchestration of the host immune response to these viral anti-
gens. According to Jegga et al.,25 those 150 genes are classified in 
autophagy, and are involved in autophagosome formation (9% of 
the G-modulated genes), autophagy regulators (45%), lysosomal 
function (17%) and lysosomal regulator (29%) genes (Fig. 4A).
The modulation of genes classified as autophagy genes (13 
genes, Fig. 4B) suggests that autophagy takes place in vivo in 
response to G expression. Moreover, these genes encode molecules 
implicated in several stages of the autophagosome biogenesis. For 
instance, ulk1 (ULK1 in humans and Ulk1 in mice, a mamma-
lian ortholog of yeast ATG1) encodes a protein kinase in yeast 
and mammals,26-29 which regulates formation of phagophores. 
The genes encoding Atg4 isoforms (atg4b and atg4c, Fig. 4B), 
encode cysteine proteases that cleave the C-terminal amino acids 
of LC3 in order to allow LC3 conjugation with phosphatidyleth-
anolamine.30,31 The atg5 and atg12 genes encode proteins that are 
part of a complex. In mammals, this complex formed by ATG12, 
ATG5, and ATG16L1 is necessary for the lipidation of LC3 and 
the elongation of the phagophore.32 On the other hand, ATG7 
and ATG10 enable the union between ATG12 and ATG5.32 The 
becn1 gene (BECN1 in humans, Becn1 in mice or VPS30/ATG6 
in yeast) encodes Becn1 in zebrafish or BECN1 in mammals, a 
key protein molecule in the class III phosphatidylinositol 3-kinase 
(PtdIns3K) complex, crucial in autophagosome formation in 
Figure 2. expression of G-TFP fusion proteins in fish and mammalian cells. hacaT or ZF4 cells were transfected with 1 μg/mL of pmTFP, pGvsv-TFP, 
pGvhsv-TFP, or pGsvcv-TFP and then viewed and photographed with an inverted fluorescence microscope 48 h post-transfection.
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1670 Autophagy Volume 10 issue 9
yeast and mammals.32 The role of the mammalian homologs of 
the zebrafish Wipi1 protein, also upregulated in zebrafish cells 
upon G expression (Fig. 4B), remains to be completely eluci-
dated.32 Interestingly, WIPI1 plays a role in xenophagic processes 
against bacteria in human cells.33 The lc3a gene (encoding the 
ortholog of mammalian MAP1LC3A) was also modulated by 
both Gs in zebrafish cells along with 2 other genes corresponding 
to proteins of the family of mammalian orthologs of yeast Atg8, 
(Gabarap and Gabarapl2/Gate-16 in zebrafish). These 3 proteins 
are involved in the elongation of the autophasome membrane in 
mammals.30 Other authors17,34-37 give a more comprehensive and 
detailed account of the functions and roles of these proteins in 
autophagy.
Type I IFN-mediated response induced by rhabdoviral Gs is 
regulated by autophagy in zebrafish cells
Once confirmed that rhabdoviral G proteins can modulate 
autophagy in vivo, we wondered whether or not a relationship 
exists between autophagy modulation and the immune response 
elicited by these proteins, such as the activation of the type I IFN 
system. To that end, cells were transfected with the rhabdoviral 
G-encoding plasmids in the presence or absence of autophagy 
chemical modulators (3MA and rapamycin) and 48 h post-trans-
fection the expression of interferon stimulated gene mx (isoforms 
A and B) was evaluated. As a positive control of activation of 
this type I IFN response, poly (I:C)-treated cells were included 
in the assay. The mx gene was chosen because Mx proteins have 
Figure 3. Rhabdoviral G-mediated autophagy in cells transfected with pm-TFP, pGvsv-TFP, pGvhsv-TFP or pGsvcv-TFP (A) and Lc3-ii/Lc3-i ratios in virus 
infected and G-transfected cells. (A), cells were fixed at 72 h after transfection with 2.5 μg/mL of pGvsv-TFP (hacaT cells) or 0.5 μg/mL of either pGvhsv-
TFP or pGsvcv-TFP (ZF4 cells), for Lc3 staining with an antibody anti-Lc3 and fluorescent visualization. (B) Whole cell lysates were obtained from cells 
transfected (as above) or infected with SVcV, VhSV, or UV irradiated viruses (SVcV-UV, VhSV-UV) at moi = 20 for 4 h, cells treated with 500 nM of rapamy-
cin (4 h) or untreated cells (control, c). Lc3-i and Lc3-ii bands were visualized by WB using an anti-Lc3 antibody, and the protein content of the stained 
bands estimated by densitometry, densitometry values were used to calculate Lc3-ii/ Lc3-i ratios. Additionally, as a protein load internal control, actin 
bands were visualized using an anti-actin antibody. Results are representative of 2 independent experiments.
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Figure 4. expression of genes related to autophagy by microarray hybridization obtained from adult zebrafish genetically immunized by intramuscular 
injection with pAe6, pAe6-Gvhsv, or pAe6-Gsvcv. Three d post-immunization, muscle samples of zebrafish intramuscularly injected with 1.5 μg of the 
plasmids were processed to obtain their gene expression profiles using commercially available whole-genome DNA oligo microarrays from Agilent. 
Autophagy-related genes differentially expressed were sub-categorized (A). The expression fold values of the genes in the sub-category autophagy, 
are tabulated (B). Gene expression values were calculated by normalizing them against pAe6-injected fish. Means and standard deviations (S.D.) were 
calculated from 3 independent experiments. Threshold for statistical significance was established at P ≤ 0.05.
proven to be very specific and sensitive markers for type I IFN 
responses.38,39
In the absence of autophagy chemical modulators, the 3 viral 
glycoproteins, Gsvcv, Gvhsv, and Gvsv, were able to signifi-
cantly upregulate the transcript expression of mx genes by 6-, 3-, 
and 2.9-fold, respectively, compared with untransfected 
cells (Fig. 5). Likewise, mx gene expression was also induced 
in cells treated with poly (I:C). In contrast, no upregulation 
of mx transcripts was observed in cells transfected with plas-
mids coding for the TFP protein alone (Fig. 5). In all 3 cases, 
3MA reduced ≥ 50% the mx gene expression (Fig. 5). 
Conversely, rapamycin induced an increase of 50% the mx 
expression in G-expressing cells. As expected, neither 3MA 
nor rapamycin had significant effects on the mx expression 
in cells transfected with the plasmid encoding TFP alone 
when compared with untransfected cells. Overall, these results 
suggest that i) autophagy is required for the activation of the 
type I IFN response by rhabdoviral Gs and ii) there is a 
synergistic effect of rapamycin and rhabdovrial Gs on type I 
IFN activation.
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Identification of the major autophagy-inducing regions of 
the Gs of VSV and VHSV
It has been reported that specific autophagy-inducing agents 
such as the Tat–BECN1 peptide may have potential for the pre-
vention and treatment of a broad range of human diseases.40 
In this context, we wondered if specific regions of rhabdoviral 
Gs might suffice to initiate the antiviral autophagy response. If 
that were the case, the identification of these protein regions/
peptides could be of crucial interest for the development of 
antiviral agents at least these rhabdoviruses. With the aim of 
identifying these potential G autophagy-inducing regions sets 
of 15-mer overlapping peptides (pepscan) spanning the entire 
sequence of the G corresponding to VHSV (07.71 serotype), 
and VSV (Indiana strain) were synthesized. Between the SVCV 
and VHSV we chose VHSV because abundant data on its G 
sequence and structure is available.41 To carry out the assays, 
cells grown in 24-well plates were treated with each of the 
15-mer synthetic peptides from the pepscan of Gvsv (HaCaT 
cells) or Gvhsv (ZF4 cells) and the induction of autophagy 
was evaluated by flow cytometry using an anti-LC3 protein 
antibody.
Three of the 43 peptides from the Gvsv pepscan induced a 
significant increase of autophagy in peptide-treated HaCaT 
cells relative to untreated cells (Fig. 6A; Fig. S5A). These 3 
autophagy-inducing peptides defined 2 separated regions located 
at the fusion and lateral domains of the protein according to 
the prefusion structure of Gvsv.42 The region 
located at the fusion domain (from amino acid 
77 to 91) (Fig. 6A, blue) was defined by one 
peptide (p84, Table 1), which increased the 
LC3 protein-associated fluorescence by »3-fold. 
The second region (from amino acid 337 to 361) 
(Fig. 6A, red) was defined by the pepscan pep-
tides p344 and p354 (Table 1), which increased 
the LC3 protein-associated fluorescence by 
≈6.5- and 3.5-fold, respectively (Fig. 6A).
Interestingly, an autophagy-inducing pep-
tide (from amino acid 99 to 113) (Fig. 6B, blue) 
in the fusion domain (p106, Table 1) was also 
identified in the sequence of Gvhsv (Fig. 6B; 
Fig. S5B). These results suggest a pivotal role 
of the fusion domain of rhabdoviral Gs in auto-
phagy activation. In fact, the p106 peptide was 
previously described as one of most important 
phosphatidylserine (PS)-binding peptide of 
Gvhsv.44 In contrast, no peptides implicated in 
the autophagy activation were found in other 
domains of Gvhsv.
To confirm the role in autophagy of the G 
inducing-peptides, mapped by pepscan, the 
presence of the lipidated form of LC3 (LC3-II), 
as analyzed by WB (Fig. 6C and D), was inves-
tigated in cells treated with those peptides. In 
the case of Gvhsv, we also included in the study 
the p2 peptide (amino acids [aa] 83 to 109 of 
Gvhsv) which overlaps with p106 and can bind 
not only PS but also phosphatidylinositol bisphosphate.45 Since 
phosphatidylinositol plays an important role in autophagy pro-
cesses,46,47 it was interesting to test whether or not p2 was also 
implicated in triggering autophagy.
In agreement with the FC data, cell treatment with the above-
mentioned Gvsv or Gvhsv autophagy-inducing peptides resulted 
in autophagy induction, as demonstrated by an increment of the 
conversion of LC3-I to LC3-II, compared with untreated cells 
or cells treated with a noninducing peptide (Np) (Fig. 6C and 
D). Thus, the LC3-II/LC3-I ratios in mammalian cells treated 
with Gvsv autophagy-inducing peptides were 2.29, 4.63, and 
2.78 for the peptides p84, p344, and 354, respectively (Fig. 6C), 
which, in FC assays, increased the LC3 fluorescence 3-, 6.5-, 
and 3.5-fold compared with untreated cells (Fig. 6A). For Gvhsv 
autophagy-inducing peptides the LC3-II/LC3-I ratios were 5.08 
and 7.01 for p106 and p2, respectively (Fig. 6D). All these results 
suggest a relationship between Gvhsv PS- and PtdIns-binding 
regions and autophagosome formation.
Major autophagy-inducing peptides of the Gs of VSV and 
VHSV inhibit viral replication
If autophagy plays an antiviral role during rhabdovirus infec-
tion and one of the viral PAMPs that activates the antiviral auto-
phagy is the G, we hypothesized that cell treatment with the 
major rhabdoviral autophagy-inducing peptides should decrease 
viral replication. To check this hypothesis, cells were treated with 
each of the autophagy-inducing peptides of VHSV or VSV Gs. 
Figure 5. Modulation of mx mediated by G-induced autophagy. ZF4 cells were transfected 
with 0.5 μg/mL of pGvsv-TFP, pGvhsv-TFP, pGsvcv-TFP, or pmTFP. Four hours post-transfec-
tion, the media were removed and replaced by fresh cell culture media or media containing 
10 mM of 3MA or 500 nM of rapamycin. Media were renewed after 24 h. At 48 h cells were 
harvested for RNA isolation and the transcript abundance of mx was analyzed by RTqPcR and 
calculated with the 2−ΔΔct method, using eef1a1l1 (eukaryotic translation elongation factor 1 
α, like 1) as endogenous control. Bars represent the mean expression ± SD of 2 independent 
experiments. **Statistically significant (P ≤ 0.05). Dotted line, expression levels of untrans-
fected control cells.
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Twenty-four hours after treatment, cells were washed and then 
infected with SVCV or VHSV (multiplicity of infection [moi] 
0.1) and the amount of newly synthesized virus particles released 
into the cell media evaluated. Those VHSV (p106) and VSV 
(p84, p344 and p354) G autophagy-inducing peptides showing 
higher LC3-II/LC3-I ratios (Fig. 6C and D) displayed a signifi-
cant antiviral activity.
On the one hand, at the maximum concentration used 
(50 µg/ml), the autophagy-inducing peptides belonging to the 
fusion domains of both Gs (Gvsv and Gvhsv) reduced the SVCV 
Figure 6. Relative fold changes in Lc3 protein expression in response to VSV and VhSV G pepscan peptide assayed by flow cytometry and immunoblot 
analysis of selected peptides. (A and B) cells grown in 24-well plates, were incubated with 25 µg/mL of each of the peptides from the Gvsv and Gvhsv 
pepscans of 15-mer peptides. After 24 h of incubation, Lc3 protein expression was measured by flow cytometry using an anti-Lc3 antibody. Fold 
increases were calculated relative to untreated cells. Data represented are the mean fold ± SD from 2 independent experiments, each performed in 
duplicate. Grey bars represent pepscan peptides that induced significant changes in Lc3 protein expression at P ≤ 0.05. Dotted lines indicate expression 
levels of untreated cells. Sequences of Gvsv and Gvhsv are represented colored by domains.41-43 Signal peptide (red checkerboard), Di (lateral domain, 
red); Dii (trimerization domain, blue); Diii (Ph domain, orange); DiV (fusion domain, yellow); cter (cterminal, magenta); unobserved cter (brown), with TM 
(black checkerboard). (C and D) Representative blots of ZF4 and hacaT cells treated with the selected G peptides from VSV (P84, P344, P354) and VhSV 
(P106) and p2 (Gvhsv PS- and phosphatidylinositol bisphosphate-binding peptide). cells were treated with 25 µg/mL of the peptides for 24 h, rapamycin 
(positive control), and a negative control peptide (Np), as a negative control. The transferred proteins were stained with anti-Lc3 antibody. Lc3-ii/Lc3-i 
ratios were calculated by densitometry and their values indicated below the blots.
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or VHSV titers ~10-fold in ZF4 cells, (Fig. 7A and 
B). Furthermore, the Gvhsv p2 peptide, which 
also exhibited a high LC3-II/LC3-I ratio expres-
sion, reduced the viral yields of VHSV and SVCV 
infections ~10-fold at the lowest concentration 
used (Fig. 7A and B). On the other hand, 50µg/
ml of Gvsv autophagy-inducing peptides, located 
toward the C-terminal of the protein (p344 and 
p354), also reduced the VHSV and SVCV titers 
~10-fold in ZF4 cells. Curiously, these peptides 
were more effective against VHSV (Fig. 7A) than 
SVCV (Fig. 7B), even though VSV and SVCV are 
phylogenetically closer to each other.48
It is noteworthy that regardless of the source 
of the autophagy-inducing peptides (Gvsv or 
Gvhsv), protection against any of the 2 viruses was 
achieved. Thus, the decrease of the viral titers prob-
ably reflects xenophagic degradation of the viruses. 
Alternatively, this may also be due to other antivi-
ral effects, which result from increased autophagy.
Discussion
The lysosomal degradation pathway of auto-
phagy has a crucial role in the defense against some 
viral infections.10 Accordingly, agents capable of 
modulating autophagy may have broad therapeu-
tic applications.5 One approach to developing such 
agents is to exploit autophagy-manipulation strat-
egies used by microbial virulence factors40 while 
another approach might use viral mechanisms. To 
that end, in this work we have studied the relation-
ship between the surface antigen (the glycoptoyein 
G) of 3 viruses belonging to the Rhabdoviridae 
family (VSV, VHSV, and SVCV) and autophagy. 
As a result, we identified functionally relevant 
short regions of the rhabdoviral Gs that induce 
autophagy and reduce virus propagation. These 
regions might be used for developing therapeutic 
applications.
First, our results showed that the activation of a 
cell antiviral autophagy upon infection might be a 
feature common to all rhabdoviruses regardless of 
the virus target host. In fact, fish rhabdoviruses, for 
which a relationship with autophagy had not been 
established previously, present a similar autophagy-
related profile as that displayed by the mammalian 
rhabdovirus VSV in both vertebrate cell lines used 
in this work (ZF4 and HaCaT) and in insects cells 
previously used.14,15
Next, we demonstrated both in vitro (cell trans-
fection assays) and in vivo (genetic immunization 
of adult zebrafish) that the G of rhabdoviruses 
is the PAMP that triggers antiviral autophagy. 
Moreover, under our experimental conditions 
Table 1. Sequence and position of the pepscan peptides in the sequence of Gvhsv and 
Gvsv
Gvhsv Gvsv
Pepscan
peptide no.a
Sequence to C terminus
Pepscan
peptide no.
Sequence to C terminus
26 TPQiTQRPPVeNiST 24 KFTiVFPhNQKGNWK
36 eNiSTYhADWDTPLY 34 KGNWKNVPSNYhYcP
46 DTPLYThPSNcRDDS 44 YhYcPSSSDLNWhND
56 cRDDSFVPiRPAQLR 54 NWhNDLiGTGLQVKM
66 PAQLRcPheFeDiNK 64 LQVKMPKShKAiQAD
76 eDiNKGLVSVPTRii 74 AiQADGWMchASKWV
86 PTRiihLPLSVTSVS 84 ASKWVTTcDFRWYGP
96 VTSVSAVASGhYLhR 94 RWYGPKYiThSiRSF
106 hYLhRVTYRVTcSTS 104 SiRSFTPSVeQcKeS
116 TcSTSFFGGQTieKT 114 QcKeSieQTKQGTWL
126 TieKTiLeAKLSRQe 124 QGTWLNPGFPPQScG
136 LSRQeATDeASKDhe 134 PQScGYATVTDAeAV
146 SKDheYPFFPePSci 144 DAeAViVQVTPhhVL
156 ePSciWMKNNVhKDi 154 PhhVLVDeYTGeWVD
166 VhKDiThYYKTPKTV 164 GeWVDSQFiNGKcSN
176 TPKTVSVDLYSRKFL 174 GKcSNDicPTVhNST
186 SRKFLNPDFieGVcT 184 VhNSTTWhSDYKVKG
196 eGVcTTSPcQThWQG 194 YKVKGLcDSNLiSTD
206 ThWQGVYWVGATPKA 204 LiSTDiTFFSeDReL
216 ATPKAhcPTSeTLeG 214 eDReLSSLGKeGTGF
226 eTLeGhLFiRThDhR 224 eGTGFRSNYFAYeTG
236 ThDhRVVKAiVAGhh 234 AYeTGDKAcKMQYcK
246 VAGhhPWGLTMAcTV 244 MQYcKhWGVRLPSGV
256 MAcTVTFcGTeWiKT 254 LPSGVWFeMADKDLF
266 eWiKTDLGDLiQVTG 264 DKDLFAAARFPecPe
276 iQVTGPGGTRKLTPN 274 PecPeGSSiSAPSQT
286 KLTPNKcVNTDiQMR 284 APSQTSVDVSLiQDV
296 DiQMRGATDDFSYLN 294 LiQDVeRiLDYSLcQ
306 FSYLNhLiTNMAQRT 304 YSLcQeTWSKiRAGL
316 MAQRTecLDAhSDiT 314 iRAGLPiSPVDLSYL
326 hSDiTASGKVSSFLL 324 DLSYLAPKNPGTGPA
336 SSFLLSKFRPShPGP 334 GTGPAFTiiNGTLKY
346 ShPGPGKAhYLLDGQ 344 GTLKYFeTRYiRVDi
356 LLDGQiMRGDcDYeA 354 iRVDiAAPiLSRMVG
366 cDYeAVVSiNYNRAQ 364 SRMVGMiSGTTTeRe
376 YNRAQYKTMNNTWKS 374 TTeReLWDDWAPYeD
386 NTWKSWKRVDNNTDG 384 APYeDVeiGPNGVLR
396 NNTDGYDGMiFGDKL 394 NGVLRTSSGYKFPLY
406 FGDKLiiPDieKYQS 404 KFPLYMiGhGMLDSG
416 eKYQSVYDSGMLVQR 414 MLDSGLhLSSKAQVF
426 MLVQRNLVeVPhLSi 424 KAQVFehPhiQDAAS
436 PhLSiVFVSNTSDLS 434 QDAASQLPDDeiLFF
446 TSDLSTNhihTNLiP 444 eiLFFGDTGLSKNPi
aThe peptides were named by the N-terminal position of their middle amino acid (8th posi-
tion) in their protein sequence.
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(transitory expression assays), cells expressing Gs 
for several days did not show signs of decreased 
viability (data not shown) in accordance with 
previous studies in which no loss of viability is 
reported in both mammalian and fish cell lines 
stably expressing rhabdoviral Gs.41,49,50
Furthermore, the inhibition of autophagy 
impaired the immune response induced by these 
proteins suggests that autophagy, most likely, is 
involved in the orchestration of the host immune 
response to these viral antigens. Similarly, ongo-
ing autophagy is needed for VSV genome ((-) 
ssRNA) detection and IFNA secretion by plas-
macytoid dendritic cells.9
In order to answer the question of how to 
exploit the rhabdoviral Gs ability to induce auto-
phagy for the possible prevention and control of 
rhabdovirus infections, our strategy was to test 
the viral protein sequences to find those regions 
that trigger autophagy in cell culture. To that 
end, a pepscan of 15-mer overlapping peptides 
spanning the whole sequence of Gvsv and Gvhsv 
were synthesized and tested. As a result, peptides 
that significantly induced autophagy and reduced 
viral infection were identified. Strikingly, some 
of the autophagy-inducing peptides were located 
in the fusion domain of both VSV and VHSV 
Gs. Likewise, induction of autophagy in HIV-1 
infected cell cultures was also triggered by the 
fusogenic activity of gp41,51 the fusion protein of 
this virus. In the case of rhabdoviruses, the fusion 
domain should not be exposed on the G surface 
in the prefusion conformation since the viral-cell 
membrane fusion takes places in the endosomes.52 
Therefore, the ability of the rhabdoviral peptides 
located at the fusion domain of the G to induce 
autophagy suggests the potential presence of pat-
tern recognition receptors leading to the activa-
tion of the autophagy signaling cascade(s) not 
only on the cell surface but also in the endosomes. 
Regarding VHSV G, the presence in its sequence 
of linear determinants that activate the type I IFN 
system has been reported (VHSV G Mx-inducing 
peptides).41 In silico studies showed that these 
VHSV G Mx-inducing peptides were exposed 
on the surface of the protein. In contrast, autophagy-inducing 
peptides identified in this work are located in the fusion domain 
of the protein and therefore are only exposed during membrane 
fusion. Taken together, these results suggest that VHSV G glyco-
protein might signal the IFN induction by means of its prefusion 
conformation (native conformation) and autophagy by means of 
its post-fusion conformation. However, more work is needed to 
confirm this hypothesis.
Despite the potential of the peptides identified in this work 
as autophagy modulators, it is not yet clear that their rep-
resented regions play the same role as part of the G molecule 
Figure 7. Antiviral effect of autophagy-inducing peptides in ZF4 cells. Titration of virus (in 
ffu/mL) recovered from cell culture media from ZF4 cells treated with 12 (white bars), 25 
(gray bars) and 50 (black bars) µg/mL of autophagy-inducing peptides from VSV or VhSV 
Gs, a negative peptide (Np) or untreated and then infected with VhSV (A) or SVcV (B). The 
results represent the mean ± SD of 2 independent experiments each performed in dupli-
cate. *, Statistically significant (P ≤ 0.05), peptide treated vs. untreated cells.
during rhabdoviral infection. Nevertheless, since these peptides 
upregulate autophagy and influence the outcome of rhabdoviral 
infections, G glycoproteins should be the target of future studies 
oriented at the modulation of autophagy for therapeutic purposes.
Materials and Methods
Cell lines and viruses
The fish cell lines ZF4 (zebrafish embryonic fibroblast)53 and 
EPC (Epithelioma Papulosum Cyprini)54 cells, both purchased 
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from the American Type Culture Collection (ATCC, #CRL-
2050 and CRL-2872, respectively), were used in this work. Cells 
were maintained at 28 °C in a 5% CO
2
 atmosphere in RPMI-
1640 Dutch modified (Gibco, 22409-015) cell culture medium 
containing 10% fetal bovine serum (FBS) (Sigma, F6178), 
1 mM pyruvate (Gibco, 11360-039), 2 mM L-glutamine (Gibco, 
25030-024), 50 µg/mL gentamicin (Gibco, 15750-060) and 
2 µg/mL fungizone (Gibco, 15290-026). The human cell line 
HaCaT was purchased from CLS Cell Lines Service GmbH 
(Eppelheim, CLS order #300493). HaCaT cells were cultured 
in high glucose DMEM medium (Sigma, D5671) supplemented 
with 2 mM L-glutamine, 10% FBS, 1 mM pyruvate, 2 mM glu-
tamine, 50 µg/mL gentamicin and 2 µg/mL fungizone, at 37 °C 
in a humidified incubator in a 5% CO
2
 atmosphere.
The SVCV isolate 56/70, isolated from carp,55 was propagated 
in ZF4 cells at 22 °C. VHSV (strain 07.71), isolated in France 
from rainbow trout (Oncorhynchus mykiss),56 was propagated in 
EPC cells at 14 °C modified from Basurco et al.57 Supernatants 
from VHSV- or SVCV-infected cell monolayers were clarified 
by centrifugation at 4,000 × g for 30 min and kept in aliquots at 
−80 °C. Clarified supernatants were used for the experiments. For 
the generation of nonreplicative SVCV and VHSV both viruses 
were UV-inactivated by 2 exposures to 1 J/cm2 as described 
for VSV inactivation9 using a Bio-Link Crosslinker BLX E312 
(Vilber Lourmat, BLX-E312). Neither of the viruses could repli-
cate after UV-irradiation (data not shown).
Antibodies
For visualization in immunofluorescence (IF), flow cytom-
etry (FC), and protein staining in western blot (WB) assays of 
human and zebrafish microtubule-associated protein 1 light 
chain-3 (LC3)-I/LC3-II, a polyclonal antibody anti-LC3A/B 
(Cell Signaling Technology, 4108) was diluted 200- (IF) 300- 
(FC) and 1,000-fold (WB). IF assays and focus-forming assays 
of infection with VHSV and SVCV were performed using the 
monoclonal antibody 2C958,59 (against the N protein of VHSV, 
VHSV-N) and BIO 331 (against SVCV-N, BioX Diagnostics, 
BIO 331) diluted 1,000- and 300-fold, respectively. A monoclo-
nal antibody anti-actin (Sigma, A2066) was used to stain human 
and zebrafish actin diluted 2,000-fold in WB assays. Goat anti-
rabbit (GAR) CFTM594 (Sigma, SAB4600107) fluorophore-
conjugated antibody diluted 500-fold was used in IF assays. 
GAR CFTM488 (Sigma, SAB4600389) fluorophore-conjugated 
antibody diluted 200-fold was used for autophagy activation/
inhibition assays of the Pepscan peptides by FC. Goat anti-rab-
bit peroxidase-conjugated antibody (GAR-Po, Sigma, A6154) 
diluted 500-fold was used in WB assays for visualization of the 
LC3 band. Rabbit anti-mouse peroxidase-conjugated (RAM-Po, 
Sigma, A9044) diluted 300-fold was used in focus forming assays 
for both SVCV and VHSV.
Viral infectivity assays
ZF4 cells, grown in 96-well plates, were infected with VHSV 
or SVCV in a final volume of 100 μl/well of culture medium 
supplemented with 2% FBS for 90 min at 14 °C or 22 °C, respec-
tively. Cells were then washed to remove unbound virus and cul-
ture media replaced with fresh RPMI 2% FBS. To test the effect 
of 3MA (Sigma, M9281) upon VHSV and SVCV infectivity, cell 
monolayers were treated with 3MA in DMSO (Sigma, 472301)/
EtOH (1:1)11 diluted 1/100 in cell culture medium to final con-
centration of 10 mM for 4 h before infection. In this case, a 
0.05% of DMSO was added to the cell culture medium in every 
condition assayed.
To test the effect of the pepscan peptides upon VHSV and 
SVCV infectivity, cell monolayers were treated with different 
peptide concentrations for 24 h prior to infection. In all cases, 
after the incubation periods untreated or treated cells were 
washed extensively with phosphate-buffered saline (PBS; 100 
mM Na
2
HPO
4
, 27 mM KCl, 17 mM KH
2
PO
4
, 1.3 M NaCl, 
pH 7.4) and infected with VHSV or SVCV as indicated above. 
At 24 h postinfection the supernatant fractions from infected cell 
cultures were harvested and the virus yields assayed by an immu-
nostaining focus assay as described below.
Viral replication assays
SVCV and VHSV replication were determined by a previ-
ously described immunostaining focus assay.60,61 EPC cells were 
incubated in 96-well plates with serial dilutions of the virus-
containing supernatant fractions at either 14 °C (VHSV) or 22 
°C (SVCV) for 24 h. Then, media were removed and cells fixed 
with a solution of 4% formaldehyde (Sigma, F1635) in PBS for 
15 min. Cells were then washed with PBS and fixed with cold 
methanol (-20 °C) for 15 min, washed again with PBS and then 
incubated with the antibodies 2C9 (VHSV) or BIO 331 (SVCV) 
in dilution buffer [0.24 mM merthiolate (Sigma, T5125), 5 g 
of Tween-20 (Merck, 655204)/liter, and 50 mg of phenol red 
(Sigma, P3532)/liter in PBS, pH 6.8]. After incubation with pri-
mary antibodies cell monolayers were washed 3 times with dis-
tilled water and incubated with RAM-Po secondary antibody for 
45 min and then washed 3 times with distilled water. Finally, 50 
μl of 1 mg/mL of diaminobenzidine (DAB, Sigma, D5637) in 
PBS containing H
2
O
2
58,61 was added to each well, and the reac-
tion was allowed to proceed until brown foci were detected with 
an inverted microscope (Nikon). Brown foci were then counted 
to determine virus titers in focus forming units (ffu)/mL.
DNA plasmids
The cDNA sequences derived from the mRNAs encoding 
the membrane surface glycoproteins of SVCV (Gsvcv, GenBank 
accession Z37505.1) and VHSV (Gvhsv, GenBank accession 
A10182.1) were synthesized by GenScript USA Inc. The syn-
thetic sequences were subcloned into pAE6, a plasmid contain-
ing the 5′-regulatory sequences of the gene encoding carp actb/ 
β-actin,20,62 following standard procedures to generate the plas-
mid constructs pAE6-Gsvcv and pAE6-Gvhsv, respectively. The 
same cDNA sequences were subcloned into the plasmid vector 
pmTFP (Allele Biotechnology, ABP-FP-TCNCS) containing the 
gene sequence of TFP)18 to obtain the DNA constructs pGsvcv-
TFP and pGvshv-TFP used in the in vitro experiments. The 
pmTFP plasmid contains the sequence of the human cytomega-
lovirus transcription promoter, a bacterial origin of replication 
for plasmid production, the simian virus 40 (SV40) polyA signal, 
and the ampicillin resistance gene sequence. For the experiments 
with the fusion protein containing the G of VSV, the construct 
pmTFP-VSV-G (Allele Biotechnology, ABP-FP-TVSVG10), 
hereafter referred to as pGvsv-TFP, was used.
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Cell transfection assays
Cell transfection assays were performed as previously 
described.63,64 Briefly, ZF4 cell monolayers, grown in culture 
flasks of 75 cm2, were detached using Tryple Select (Gibco, 
12563-029), washed, resuspended in cell culture medium sup-
plemented with 10% FBS and dispensed into 24- or 96-well cell 
culture plates. The following day, plasmid DNA was incubated 
with 0.3 µl of FuGene 6 (Promega, E2691)/100 ng of pDNA for 
30 min in RPMI-1640 without FBS. The mixes were then added 
(1/5 of the total volume of the culture medium in each well) to 
the wells containing the cells. Plasmid DNA concentrations, 
temperatures, and times are indicated for each experiment. In 
HaCaT, cells transfection mixes (0.3 µl of FuGene 6/250 ng of 
pmTFP or pGvsv-TFP plasmid) were performed using DMEM 
cell culture medium and added to cells in suspension. Then cells 
were seeded and incubated at 37 °C for the times indicated in 
each experiment.
Immunofluorescence assays
Untreated-, transfected-, or infected-cell monolayers were 
fixed with a 4% formaldehyde solution in PBS for 15 min at 
room temperature (RT). After washing the fixed cells, plates 
were further fixed with cold methanol (-20 °C) for 15 min. Cell 
monolayers were then incubated overnight at 4 °C with the anti-
LC3 antibody in dilution buffer (PBS with 0.03% Triton X 100 
[Sigma, T8787]) and 5% of albumin from bovine serum (BSA, 
Sigma, A2153). After that, monolayers were washed again and 
incubated with GAR CFTM594 (in dilution buffer) for 1 h to 
visualize LC3. Finally, cells were washed and stained with 1 µg/
mL of 4′-6-Diamidino-2-phenylindole (DAPI) for 10 min. Cell 
monolayers were then viewed and photographed with an inverted 
fluorescence microscope (Nikon Eclipse TE2000-U; Nikon 
Instruments, Inc., NY) provided with a digital camera (Nikon 
DS-1QM, Nikon Instruments, Inc., NY).
Fusion assays
To assess the functionality of the G ectodomain of the G-TFP 
fusion proteins encoded in the plasmids, ZF4 cells were trans-
fected in 96-well plates as indicated above with 0.5 µg/mL of 
pGsvcv-TFP, pGvhsv-TFP, or pGvsv-TFP. After 3 d, cell culture 
media were removed, cells were washed and cell membrane fusion 
was triggered by incubating the cells with fusion medium60 at 
pH 6 for 30 min. Media were then removed and cell monolayers 
were washed and subsequently incubated at room temperature 
with fusion medium at pH 7.5 for 2 h. Finally, cells were fixed 
with a 4% formaldehyde solution (in PBS) for 15 min and then 
with cold methanol (−20 °C) for 15 min. Cell nuclei were stained 
with DAPI (1 µg/mL) for 10 min and washed again with PBS. 
Cell monolayers were then viewed and photographed with an 
inverted fluorescence microscope provided with a digital camera.
In vitro gene expression assays by reverse transcriptase 
quantitative polymerase chain reaction (RTqPCR)
The transcript expression levels of the interferon-stimulated 
gene (ISG) mx (both isoforms A and B) were evaluated in ZF4 
cells at 48 h post-transfection with G-TFP-encoding plasmids in 
the presence or absence of 3MA (10 mM) or rapamycin (500 nM; 
Sigma, R8781). Cells treated with 40 µg/mL of polyinosine poly-
cytidylic acid (poly (I:C), P1038, Sigma) for 18 h were used as a 
positive control of mx induction. After the different incubation 
time periods, the medium was removed, and cells processed for 
total RNA extraction as indicated below. The mx levels were eval-
uated by RTqPCR using specific primers (Table S1) and SYBR 
green (as indicated below). The mx induction assays results were 
analyzed by using the 2−ΔΔCt method,65 and the eef1a1l1 gene as 
endogenous control. Control cells (untransfected and untreated 
cells) served as calibrator and folds were calculated by the for-
mula transfected cells/untransfected cells.
Zebrafish
Adult zebrafish (Danio rerio) of 2 to 3 g (≈4 cm in length) 
were obtained from a local pet shop and maintained at 28 °C 
in 30 l tanks equipped with a re-circulating dechlorinated water 
system. Fish were fed daily with a commercial feed diet. Prior to 
experiments, fish were acclimatized to laboratory conditions for 
at least 2 wk. All experiments with live animals (zebrafish) were 
performed using protocols approved by the European Union 
Council Guidelines (86/609/EU).
Genetic immunization of zebrafish with pAE6-G plasmids
Adult zebrafish were intramuscularly injected (n = 4) with 10 
μl of a solution containing 1.5 μg of pAE6-Gsvcv, pAE6-Gvhsv 
or pAE6 in PBS. Prior to injections, zebrafish were anesthetized 
by immersion in 50 μg/mL buffered tricaine methanesulfonate 
(MS-222; Sigma, E10521). Three d post-injection muscle sam-
ples were excised from the injection site and total RNA extracted 
as indicated below. First, G expression was analyzed by RTqPCR 
using specific primers and probes for VHSV and SVCV Gs 
(Table S1) and calculated with the 2−ΔCt method using the 
eef1a1l1 as endogenous control as mentioned above. Next, RNA 
samples were used for microarray assays.
RNA isolation
The E.Z.N.A HP Total RNA kit (Omega bio-tek, R6812) 
and E.Z.N.A HP Tissue RNA kit (Omega bio-tek, R6688), 
for the in vitro and the in vivo experiments, respectively, were 
used for total RNA extraction in accordance with instructions 
provided by the manufacturer. Isolated RNAs were stored at 
−80 °C until used. For the microarray gene expression experi-
ments, RNA samples were grouped into pools of 4 muscle sam-
ples from 4 different zebrafish for each treatment.
cDNA synthesis and RT-qPCR assays
For the in vivo G expression assays individual muscle sam-
ples were used. One microgram of RNA, as estimated by a 
NanoDrop® Spectrophotometer (Nanodrop Technologies, 
Wilmington, DE, USA) was used to obtain the cDNA using the 
Moloney murine leukemia virus reverse transcriptase (M-MLV, 
Invitrogen, 28025-013) as previously described.66 Quantitative 
PCR was then performed using the ABI PRISM 7,300 System 
(Applied Biosystems NY, USA) as previously described.41 Primers 
and probes used in both in vitro and in vivo expression assays 
are listed in Table S1. Reactions were performed in a total 
volume of 20 μl comprising 2 μl of cDNA reaction mixture, 
900 nM of each primer, 10 μl of TaqMan universal PCR mas-
ter mix (Applied Biosystems, 4304437) with 200 nM of probe 
or 10 μl of SYBR green PCR master mix (Applied Biosystems, 
4309155). The cycling conditions were 50 °C for 2 min and 
95 °C for 10 min, followed by 40 cycles at 95 °C for 15 s and 
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60 °C for 1 min. Nontemplate controls (NTCs) and controls 
without reverse transcriptase were included for each gene in all 
RT-qPCR assays (data not shown).
RNA labeling and microarray hybridization
Microarray hybridizations were performed using the 
ZEBRAFISH v. Two (ID 026437) 4 × 44 K Agilent oligonu-
cleotide microarray using single-color labeling. Standard meth-
ods were used for all processes according to manufacturer’s 
instructions (Agilent Technologies). Briefly, each amplified and 
labeled sample was hybridized at 65 °C for 17 h. Microarrays 
were scanned and one-channel TIFF images (FEATURE 
EXTRACTION software v. 10.4.0.0) were imported into 
GENESPRING software (GX v.11.0) for preliminary analysis. 
Microarray data described in accordance with MIAME guide-
lines was submitted to the Gene Expression Omnibus (GEO) 
database (no. GSE49626).
Normalizations were performed by correcting the individual 
probe fluorescence in each microarray with the sum of all the 
fluorescent values according to the formula, fluorescence of each 
probe/sum of all of the probe fluorescences per microarray. After 
normalization, outlier values (defined by those fluorescence val-
ues > or < mean ± standard deviation per probe) were identi-
fied and eliminated (masked) from the calculations programmed 
in Origin pro 8.6 (OriginLab Corporation, Northampton, MA 
USA). Comparisons with the pAE6 plasmid were calculated for 
each probe by using the following formula, fluorescent value 
from zebrafish injected with pAE6-Gvhsv or pAE6-Gsvcv plas-
mids/mean fluorescent value from zebrafish injected with pAE6 
(n = 4). Means and standard deviations of the folds were then 
calculated (n = 4). A double simultaneous criterion to define dif-
ferentially expressed gene transcripts was used: i) genes with folds 
> 1.5 or < 0.66 and ii) genes with folds deviated from the null 
hypothesis at P < 0.05.
Classification of zebrafish genes in autophagy-lysosomal 
related pathways
A list of human gene symbols classified as participants in auto-
phagy and autophagy related-processes25 were used to search for 
those genes related to authophagy present in the zebrafish micro-
array. The zebrafish orthologs (of genes in the list mentioned 
above), autophagy-related gene symbols and their associated folds, 
standard deviations, and P values were extracted from the micro-
array data by using a macro in Excel (Microsoft Corporation).
Pepscans derived from the sequences of the glycoproteins G 
(Gs) of VSV and VHSV
The synthesis of the 15-mer peptides with an overlap of 5 
amino acids (aa) and spanning the cDNA-derived aa sequence of 
the VHSV07.71 G67 and VSV G68 (GenBank accession numbers 
A10182 and X03633, respectively) was performed by Mimotopes 
Pty Ltd. The pepscan peptides (Table 1) were named by a num-
ber corresponding to the position of their middle aa (8th posi-
tion) in their corresponding G. The Peptide p2 (from aa 82 to 
109 of VHSV G (IIHLPLSVTSVSAVASGHYLHRVTYRVT) 
was synthesized by Clontech. Peptides were diluted in water to a 
final concentration of 2 mg/mL.
Evaluation of the autophagy induced by VHSV and VSV G 
peptides by flow cytometry (FC)
ZF4 and HaCaT cells grown in 24-well plates were treated 
with 25 µg/mL of each of the VHSV and VSV G pepscan pep-
tides, respectively, for 24 h (at 28 °C for ZF4 cells and 37 °C for 
HaCaT cells). In all cases, after the incubation the expression 
of the LC3 protein was quantified by FC following methologies 
previously described.69 Briefly, peptide-treated cell monolayers 
were permeabilized with 0.05% saponin (Sigma, S4521) and 
incubated with anti-LC3 antibody diluted 200-fold in FACS 
buffer consisting of PBS (100 mM Na
2
HPO
4
, 27 mM KCl, 17 
mM KH
2
PO
4
, 1.3 M NaCl, pH 7.4), 0.05% saponin and goat 
serum (Sigma, G6767) for 1 h at RT. After washing, cell mono-
layers were incubated with GAR CF488A-conjugated secondary 
antibody diluted 200-fold with FACS buffer for 30 min at RT. 
After washing, cell monolayers were detached and fixed with 1% 
paraformaldehyde. The expression of LC3 was analyzed with a 
BD FACS CantoTM II flow cytometer (BD Biosciences) using the 
FACSDiva v6.3.1 (Becton Dickinson) software. For each sample 
10,000 cells (events) were analyzed. The total fluorescence in the 
selected gate for each peptide was calculated by multiplying the 
mean fluorescence intensity by their event count. To compare dif-
ferent experiments, the results of each experiment were normal-
ized by the mean fluorescence of all the peptides and expressed as 
relative to untreated cells (fluorescence of peptide-treated cells/
fluorescence of control cells). The results are the means and stan-
dard deviations from 2 different independent experiments each 
performed in duplicate.
In vitro cell viability assays
To exclude nonspecific effects of the autophagy regulators 
(3MA and rapamycin) due to cellular toxicity, cell viability was 
quantified by using an MTT (3-(4,5-Dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium bromide) Cell Titer 96 Non-
Radioactive Cell Proliferation Assay (Promega, G109A) following 
the manufacturer instructions. Cytotoxicity was assayed 48 h 
after ZF4 or HaCaT cell monolayers were exposed to different 
concentrations of 3MA (2 to 12 mM) or rapamycin (200 to 600 
nM).
Western blot assays
ZF4 or HaCaT cells were grown on 24-well plates in culture 
medium supplemented with 10% FBS at 28 °C or 37 °C, respec-
tively. After 24 h, the different treatments (3MA, rapamycin, 
pepscan peptides, or plasmids) were added. Once the treatments 
were finished, culture media were removed and cell monolayers 
were resuspended in 500 µl of PBS with a cocktail of protease 
inhibitors (Sigma, P8340). Cells were then frozen/thawed 4 
times and protein concentration adjusted before loading pro-
tein samples onto the gel. Samples were loaded in Tris–Glycine 
sodium dodecyl sulfate 15% polyacrylamide gels under reduc-
ing conditions. Electrophoresis was performed at 100 V for 90 
min. For blotting, the proteins in the gel were transferred for 
75 min at 100 V in transfer buffer (2.5 mM Tris, 9 mM gly-
cine, 20% methanol) to nitrocellulose membranes (BioRad, 162-
0115). The membranes were then blocked with 8% dry milk, 
0.05% Tween-20 in PBS and incubated with primary antibodies 
in PBS containing 5% BSA and 0.1% Tween-20 as indicated by 
the manufacturer. Membranes were then washed 3 times with 
PBS containing 0.05% Tween-20 for 15 min before incubation 
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